Patents by Inventor Steven Mehrman

Steven Mehrman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9024009
    Abstract: The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: May 5, 2015
    Assignees: Janssen Pharmaceutica N.V., Mitsubishi Tanabe Pharma Corporation
    Inventors: Ahmed F. Abdel-Magid, Maureen Chislom, Steven Mehrman, Lorraine Scott, Kenneth M. Wells, Fan Zhang-Plasket, Sumihiro Nomura, Mitsuya Hongu, Yuichi Koga
  • Publication number: 20090233874
    Abstract: The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney.
    Type: Application
    Filed: September 9, 2008
    Publication date: September 17, 2009
    Inventors: Ahmed F. Abdel-Magid, Maureen Chisholm, Steven Mehrman, Lorraine Scott, Kenneth M. Wells, Fan Zhang-Plasket, Sumihiro Nomura, Mitsuya Hongu, Yuichi Koga
  • Patent number: 7582753
    Abstract: The present invention is directed to a novel process for the preparation of benzo[e][1,2,4]triazepin-2-one derivatives, useful in the preparation of gastrin and cholecystokinin receptor ligands.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: September 1, 2009
    Assignee: JanssenPharmaceutica, NV
    Inventors: Ahmed F. Abdel-Magid, Luigi Anzalone, Judith Cohen, Steven Mehrman, Frank Villani
  • Patent number: 7560459
    Abstract: The present invention is directed to novel compounds of the formula (I) wherein X, R1, R2, R3, R4, R5 and R6 are as described in the specification, processes for the preparation of and pharmaceutical compositions comprising said derivatives. The compounds of the present invention are useful for the treatment of epilepsy. The invention is further directed to a process for the preparation of compounds of formula (XX), wherein X, R3, R4, R5 and R6 are as described in the specification.
    Type: Grant
    Filed: November 2, 2005
    Date of Patent: July 14, 2009
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Ahmed Abdel-Magid, Cynthia Maryanoff, Steven Mehrman, Allen B. Reitz, Bruce Maryanoff
  • Publication number: 20070066819
    Abstract: The present invention is directed to a novel process for the preparation of benzo[e][1,2,4]triazepin-2-one derivatives, useful in the preparation of gastrin and cholecystokinin receptor ligands.
    Type: Application
    Filed: September 14, 2006
    Publication date: March 22, 2007
    Inventors: Ahmed Abdel-Magid, Luigi Anzalone, Judith Cohen, Steven Mehrman, Frank Villani
  • Publication number: 20070060649
    Abstract: The present invention is directed to a novel lysine salts, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by PPAR delta.
    Type: Application
    Filed: September 13, 2006
    Publication date: March 15, 2007
    Inventors: Ahmed Abdel-Magid, Steven Mehrman, Armin Roessier
  • Publication number: 20060276528
    Abstract: The present invention is directed to novel benzo-fused heteroaryl sulfamide derivatives, pharmaceutical compositions containing them and their use in the treatment of epilepsy and related disorders. The present invention is further directed to a crystalline form of N-(benzo[b]thien-3-ylmethyl)-sulfamide and a process for its preparation.
    Type: Application
    Filed: February 22, 2006
    Publication date: December 7, 2006
    Inventors: Ahmed Abdel-Magid, Bruce Maryanoff, Steven Mehrman, Michael Parker, Allen Reitz
  • Publication number: 20060270856
    Abstract: The present invention is directed to novel process for the preparation of sulfonylimine and sulfamide derivatives.
    Type: Application
    Filed: April 19, 2006
    Publication date: November 30, 2006
    Inventors: Ahmed Abdel-Magid, Steven Mehrman
  • Patent number: 7060725
    Abstract: The present invention is directed to novel compounds of the formula (I) wherein X, R1, R2, R3, R4, R5 and R6 are as described in the specification, processes for the preparation of and pharmaceutical compositions comprising said derivatives. The compounds of the present invention are useful for the treatment of epilepsy. The invention is further directed to a process for the preparation of compounds of formula (XX), wherein X, R3, R4, R5 and R6 are as described in the specification.
    Type: Grant
    Filed: May 8, 2003
    Date of Patent: June 13, 2006
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Ahmed Abdel-Magid, Cynthia Maryanoff, Steven Mehrman, Kirk Sorgi, Frank Villani, Cheryl Kordik, Allen B. Reitz, Bruce Maryanoff
  • Publication number: 20060058373
    Abstract: The present invention is directed to novel compounds of the formula (I) wherein X, R1, R2, R3, R4, R5 and R6 are as described in the specification, processes for the preparation of and pharmaceutical compositions comprising said derivatives. The compounds of the present invention are useful for the treatment of epilepsy. The invention is further directed to a process for the preparation of compounds of formula (XX), wherein X, R3, R4, R5 and R6 are as described in the specification.
    Type: Application
    Filed: November 2, 2005
    Publication date: March 16, 2006
    Inventors: Ahmed Abdel-Magid, Cynthia Maryanoff, Steven Mehrman, Allen Reitz, Bruce Maryanoff
  • Publication number: 20040038911
    Abstract: The present invention is directed to novel compounds of the formula (I) 1
    Type: Application
    Filed: May 8, 2003
    Publication date: February 26, 2004
    Inventors: Ahmed Abdel-Magid, Cynthia Maryanoff, Steven Mehrman, Kirk Sorgi, Frank Villani, Cheryl Kordik, Allen B. Reitz, Bruce Maryanoff